News for Inogen, Inc. (INGN)

Needham's Mike Matson upgrades Inogen to Buy, citing turnaround progress, margin gains, and path to EBITDA breakeven by 2025.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

On May 22, 2025, Inogen (INGN) received a significant upgrade from the analyst firm Needham. The analyst, Mike Matson, has elevated the company's rating from a

In a recent update, Needham has elevated its rating for Inogen (INGN) from Hold to Buy, setting a price target of $12. The firm cites substantial advancements b

Inogen, Inc. (NASDAQ:INGN) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ETCompany ParticipantsRyan Peterson - Investor RelationsKevin Smith -...

Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

\n[url=\

\n Inogen Inc. (INGN) will announce its Q1 2025 financial results on May 7, 2025, post-market close. A conference call discussing the results is scheduled

BOSTON, April 15, 2025 /PRNewswire/ -- Below is the March 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE:ASG).

Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

[url="]Inogen, Inc.[/url] (Nasdaq: [url="]INGN[/url]), a medical technology company offering innovative respiratory products for use in the homecare setting, t

Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Expanding product portfolio and high prospects for POC raise optimism for INGN stock

On March 3, 2025, Smith Kevin Raymond Merrill, CEO and President of Inogen Inc, purchased 11,709 shares of Inogen Inc (INGN). Following this transaction, the in

On March 3, 2025, Michael Bourque, Executive Vice President, Chief Financial Officer & Treasurer of Inogen Inc, purchased 3,000 shares of the company. Following

Inogen shows solid B2B growth, but guidance and margin issues hurt sentiment. Learn why INGN stock is a speculative play with long-term growth potential.

Total Revenue (Q4 2024): $80.1 million, a 5.5% increase year-over-year.Domestic B2B Revenue (Q4 2024): $22.4 million, a 24.1% increase year-over-year.Internati

Feb 25, 2025 / 10:00PM GMTOperator Welcome to Inogen's fourth-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is b

Inogen, Inc. (NASDAQ:INGN) Q4 2024 Earnings Conference Call February 25, 2025 5:00 PM ETCompany ParticipantsRyan Peterson – Investor RelationsKevin Smith –...